Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.4200 (7.43%) ($28.5900 - $31.1700) on Wed. Nov. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.4% (three month average) | RSI | 47 | Latest Price | $30.4200(7.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(57%) ARKG(55%) IWC(54%) IBUY(53%) | Factors Impacting EDIT price | EDIT will decline at least -2.2% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) EDOC(-8%) TBT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.2% (StdDev 4.4%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $31.9 | 5 Day Moving Average | $30.76(-1.11%) | 10 Day Moving Average | $31.44(-3.24%) | 20 Day Moving Average | $31.9(-4.64%) | To recent high | -18.1% | To recent low | 12.3% | Market Cap | $1.889b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |